IVF Valuation

INVO Fertility Inc

Add to Watchlist

Advanced Chart

0.844

-0.037(-4.198%)1D

Overview
Forecast
Valuation
Earnings

IVF Relative Valuation

IVF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IVF is overvalued; if below, it's undervalued.

Historical Valuation

INVO Fertility Inc (IVF) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -0.93. The fair price of INVO Fertility Inc (IVF) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 0.84 USD , INVO Fertility Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：0.84

Fair

Undervalued

-0.27

Trailing

Forward

0.00

EV/EBITDA

INVO Fertility Inc. (IVF) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-1.04

EV/EBIT

INVO Fertility Inc. (IVF) has a current EV/EBIT of -1.04. The 5-year average EV/EBIT is -1.90. The thresholds are as follows: Strongly Undervalued below -3.11, Undervalued between -3.11 and -2.50, Fairly Valued between -1.29 and -2.50, Overvalued between -1.29 and -0.68, and Strongly Overvalued above -0.68. The current Forward EV/EBIT of -1.04 falls within the Overvalued range.

0.53

INVO Fertility Inc. (IVF) has a current PS of 0.53. The 5-year average PS is 0.39. The thresholds are as follows: Strongly Undervalued below 0.04, Undervalued between 0.04 and 0.22, Fairly Valued between 0.57 and 0.22, Overvalued between 0.57 and 0.75, and Strongly Overvalued above 0.75. The current Forward PS of 0.53 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

INVO Fertility Inc. (IVF) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

INVO Fertility Inc. (IVF) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.07. The thresholds are as follows: Strongly Undervalued below -0.23, Undervalued between -0.23 and -0.15, Fairly Valued between 0.01 and -0.15, Overvalued between 0.01 and 0.09, and Strongly Overvalued above 0.09. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

INVO Fertility Inc (IVF) has a current Price-to-Book (P/B) ratio of -0.09. Compared to its 3-year average P/B ratio of -0.11 , the current P/B ratio is approximately -11.56% higher. Relative to its 5-year average P/B ratio of -0.11, the current P/B ratio is about -11.56% higher. INVO Fertility Inc (IVF) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -256.33%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -256.33% , the current FCF yield is about -100.00% lower.

-0.09

P/B

Median3y

-0.11

Median5y

-0.11

-172.24

FCF Yield

Median3y

-256.33

Median5y

-256.33

Competitors Valuation Multiple

The average P/S ratio for IVF's competitors is 0.70, providing a benchmark for relative valuation. INVO Fertility Inc Corp (IVF) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 1.47%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Mobile-health Network Solutions

Loss

4.32M

SBEV.A

Splash Beverage Group Inc

Intelligent Bio Solutions Inc

Loss

15.95%

12.21M

Performance Decomposition

Market capitalization of IVF decreased by 96.50% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -122.25 to -172.19.

The secondary factor is the Revenue Growth, contributed 1.47%to the performance.

Overall, the performance of IVF in the past 1 year is driven by Margin Expansion. Which is more sustainable.

1.47%

1.84M → 1.86M

Revenue Growth

40.85%

-122.25 → -172.19

Margin Expansion

-138.82%

0.04 → -0.02

P/E Change

-96.50%